AEB071
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
de Novo Liver Transplantation
Conditions
de Novo Liver Transplantation
Trial Timeline
Oct 1, 2007 → —
NCT ID
NCT00545259About AEB071
AEB071 is a phase 1 stage product being developed by Novartis for de Novo Liver Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00545259. Target conditions include de Novo Liver Transplantation.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (7)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01430416 | Phase 1 | Completed |
| NCT01402440 | Phase 1 | Terminated |
| NCT00615693 | Phase 2 | Completed |
| NCT00545259 | Phase 1 | Completed |
| NCT00492869 | Phase 1/2 | Completed |
| NCT00416546 | Phase 1 | Completed |
| NCT00409929 | Phase 1 | Completed |
Competing Products
19 competing products in de Novo Liver Transplantation